Across the UK’s care ecosystem - from care homes and domiciliary care to hospitals and mobility providers - the issue of pressure ulcers persists as one of the most preventable yet costly healthcare failures.

Every year, over 700,000 people suffer from pressure ulcers. The physical pain, infection risk, and loss of dignity are profound - but so too are the financial consequences. The cost of treating pressure ulcers in the UK alone exceeds £3.8 billion annually, representing around 4% of total NHS spend.

For care providers, this is more than a clinical issue - it’s a reputational and regulatory challenge. Families expect better. The Care Quality Commission demands better. And technology now makes ‘better’ achievable. Graphene Trace’s Sensore platform brings a new standard of intelligent prevention to the care sector - combining breakthrough materials science with human-centred design to help carers act earlier, prevent harm, and protect dignity.

Scott Dean

CEO

Share